Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mocroft

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 6, 2020
A new health care index predicts short term mortality for TB and HIV co-infected peopleA O Roen, D Podlekareva, R F Miller, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
HIV Medicine|May 12, 2015
Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across EuropeM Mansfeld, A Skrahina, L Shepherd, et al.
HIV Medicine|November 20, 2020
Healthcare delivery for HIV-positive people with tuberculosis in EuropeA K Bentzon, A Panteleev, V Mitsura, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patientsD N Podlekareva, D Grint, F A Post, et al.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
HIV Medicine|March 4, 2024
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohortO Fursa, W Bannister, B Neesgaard, et al.
HIV Medicine|December 23, 2017
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohortA Roen, K Laut, A Pelchen-Matthews, et al.
HIV Medicine|September 1, 2017
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive peopleL Shepherd, Á H Borges, R Harvey, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 6, 2020
A new health care index predicts short term mortality for TB and HIV co-infected peopleA O Roen, D Podlekareva, R F Miller, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
HIV Medicine|May 12, 2015
Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across EuropeM Mansfeld, A Skrahina, L Shepherd, et al.
HIV Medicine|November 20, 2020
Healthcare delivery for HIV-positive people with tuberculosis in EuropeA K Bentzon, A Panteleev, V Mitsura, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patientsD N Podlekareva, D Grint, F A Post, et al.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
HIV Medicine|March 4, 2024
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohortO Fursa, W Bannister, B Neesgaard, et al.
HIV Medicine|December 23, 2017
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohortA Roen, K Laut, A Pelchen-Matthews, et al.
HIV Medicine|September 1, 2017
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive peopleL Shepherd, Á H Borges, R Harvey, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Pageof 12